Federal grants to Ridgeline Therapeutics, Inc.
Ridgeline Therapeutics, Inc. in Houston, Texas received $6.3 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Aging Research, with $5.9 million. In fiscal 2025 it was awarded $1.8 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$6.3 million
- Awards4
- Awarded in FY 2025$1.8 million
- Largest award$4.2 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $1.2 million |
| FY 2022 | 2 | $1.2 million |
| FY 2023 | 2 | $1.8 million |
| FY 2024 | 1 | $236,538 |
| FY 2025 | 2 | $1.8 million |
Programs that fund Ridgeline Therapeutics, Inc.
| Program | Awards | Amount |
|---|---|---|
| Aging Research | 3 | $5.9 million |
| Military Medical Research and Development | 1 | $498,988 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $5.8 million |
| Department of Defense | 1 | $498,988 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Preclinical development of a novel therapeutic to rejuvenate aging muscle stem cells and enhance muscle strength and function post hip fracture - muscle-aging is defined by progressive declines in mass and strength that poses a high risk for falls, fatal injury, and trauma-related fractures among ol | Aging Research | September 20, 2021 | $4.2 million |
| Preclinical validation of a novel adjunct small molecule drug to prevent muscle loss and enhance weight loss in older adults - abstract obesity is a chronic health concern in the US1, affecting more than 40% of ADULTS2 and resulting in devastating health COMPLICATIONS3-4. Annual medical costs to tre | Aging Research | September 19, 2025 | $1.3 million |
| Transformative drugs to prevent osteoarthritis and speed recovery following traumatic joint injury in military and civilian populations | Military Medical Research and Development | June 23, 2025 | $498,988 |
| A novel small molecule oral therapeutic to prevent and reverse skeletal muscle atrophy in aging adults - limited muscle use is widespread in older adults (e.g., post-injury immobilization, bed rest) and typically leads to disuse-induced muscular atrophy defined by substantial loss of muscle mass, st | Aging Research | August 23, 2023 | $322,432 |
Questions people ask
How much federal grant money does Ridgeline Therapeutics, Inc. get?
$6.3 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Ridgeline Therapeutics, Inc. the most?
The Department of Health and Human Services, with $5.8 million in 3 awards. The Department of Defense follow.
What is Ridgeline Therapeutics, Inc.'s largest federal grant?
$4.2 million under Aging Research, with its first action in the period on September 20, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Ridgeline Therapeutics, Inc.?
Its largest are Aging Research and Military Medical Research and Development.
Other grant recipients in Houston
- Baylor College of Medicine
- The Univeristy of Texas M.D. Anderson Cancer Center
- Metropolitan Transit Authority of Harris County
- University of Texas Health Science Center at Houston
- Harris County
- University of Houston System
- William Marsh Rice University
- City of Houston
Largest federal grant recipients in Texas · Federal grants in Texas